Nature Communications (Jun 2021)

P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas

  • Liat Rousso-Noori,
  • Ignacio Mastandrea,
  • Shauli Talmor,
  • Tova Waks,
  • Anat Globerson Levin,
  • Maarja Haugas,
  • Tambet Teesalu,
  • Luis Alvarez-Vallina,
  • Zelig Eshhar,
  • Dinorah Friedmann-Morvinski

DOI
https://doi.org/10.1038/s41467-021-23817-2
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 13

Abstract

Read online

Chimeric antigen receptor (CAR) T cell therapy has been proposed as a promising approach for treating glioblastoma. Here the authors show that p32 is expressed in murine and human glioma and that p32-directed CAR-T cells promote anti-tumor responses in preclinical models by targeting glioma cells and tumor derived endothelial cells.